+148.5%
MRNA vs CHD
-6.9%
+155.4%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 6mo.
| Period | Portfolio | CHD | Excess | Alpha |
|---|---|---|---|---|
| 1D | +0.7% | -1.3% | +2.1% | +0.5% |
| 7D | -8.2% | -4.7% | -3.5% | -9.2% |
| 30D | +125.6% | -8.3% | +133.9% | +120.4% |
| 3M | +197.1% | -4.0% | +201.1% | +193.7% |
| 6M | +148.5% | -6.5% | +155.0% | +151.4% |
| All | +148.5% | -6.9% | +155.4% | +151.4% |
Cumulative growth
Daily Returns
Daily percentage return beside CHD.
Daily Out/Under-Performance
Portfolio return minus CHD return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × CHD return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 6mo: compounded portfolio wealth divided by compounded CHD wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
6mo analysis · Full analysis span regression · 6 months rolling